Sanuwave Health receives $5 million payment for patent portfolio sale

Published 21/08/2025, 21:58
Sanuwave Health receives $5 million payment for patent portfolio sale

Sanuwave Health, Inc . (NASDAQ:SNWV) announced Thursday that it has received a $5 million cash payment from a third-party licensee following the exercise of an option to acquire a portfolio of Sanuwave patents related to intravascular shockwave applications. The information is based on a statement in the company’s SEC filing.

According to the filing, Sanuwave previously entered into an exclusive license and option agreement with the licensee on March 6, 2024. Under the original agreement, Sanuwave granted the licensee exclusive rights to the patents and an option to purchase them in exchange for a one-time payment of $2.5 million.

On Thursday, the licensee exercised the option to acquire the patents, resulting in the $5 million payment to Sanuwave. The company’s common stock is listed on the Nasdaq Stock Market under the symbol SNWV.

No additional details regarding the identity of the licensee or the specific patents involved were disclosed in the filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.